Allergan (AGN), Mylan (MYL) Sees Short Interest Rise, Gilead (GILD) Fall in Pharma Sector - Guggenheim
Get Alerts ARLZ Hot Sheet
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Guggenheim analyst Louise Chen provided a quick analysis of the latest short interest data (09/15/16) in the pharma sector.
Chen notes the largest increase in short interest is Aralez (NASDAQ: ARLZ) at +26.3%, followed closely by Allergan (NYSE: AGN) at +24.7%.
The company with the largest decrease in short interest is Gilead (NASDAQ: GILD) at -10.4%.
Other Notables:
Mylan, Inc. (NYSE: MYL) short interest up 17.7% to 25,313,358 shares.
Valeant Pharmaceuticals Inc. (NYSE: VRX) short interest up 1.2% to 26,396,945.
Bristol Myers Squibb (NYSE: BMY) short interest up 13.1% to 13,960,166 shares
Endo Pharmaceuticals (NASDAQ: ENDP) short interest up 16.7% to 16,003,377 shares.
Celgene (NASDAQ: CELG) short interest up 18.7% to 6,953,530 shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tuta Mail Files Google Complaint Under EU Tech Rules - Reuters
- Preferred Bank (PFBC) PT Raised to $86 at DA Davidson
- PVR Inox Ltd (PVRINOX:IN) PT Lowered to INR1,870 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, Short Sales, Trader TalkRelated Entities
Louise Chen, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!